AngioDynamics Osake

AngioDynamics EBIT per osake

EBIT per osake yhtiöstä AngioDynamics (ANGO) 19.8.2026 päivämäärällä on −0,96 USD. Edellisenä vuonna EBIT per osake oli −0,96 USD — muutos −0,36 % (korkeampi).

EBIT per osake

−0,96USD

YoY

−0,36%

Viimeksi päivitetty:

EBIT per osake yhtiöstä AngioDynamics on 2026 −0,96 USD. EBIT per osake yhtiöstä AngioDynamics oli 2025 −0,96 USD. Se laskee −0,36% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

AngioDynamics Osakeanalyysi

Mitä AngioDynamics tekee? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset AngioDynamics osakkeesta

Yhtiön AngioDynamics EBIT per osake on −0,96 USD vuonna 2026.

EBIT per osake yhtiöstä AngioDynamics muuttui arvosta −0,96 USD arvoon −0,96 USD, mikä edustaa −0,36 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBIT per osake AngioDynamics:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBIT per osake mittaa operatiivisen voiton, joka on kohdistettu kullekin ulkona olevalle osakkeelle.

Access this data via the Eulerpool API

Tuloslaskelma — AngioDynamics

Kaikki tunnusluvut — AngioDynamics